CJC-1295 No DAC vs Mod GRF 1-29: What Should Researchers Compare?
Researchers searching for CJC-1295 No DAC frequently encounter another name in commercial research catalogs: Mod GRF (1-29) or Modified GRF (1-29).
Peptides Lab US lists its CJC-1295 No DAC 5mg research product here:
https://peptideslabus.com/products/cjc-1295-no-dac-5mg-research-peptide
Browse the wider CJC-1295 catalog:
https://peptideslabus.com/products?q=CJC-1295
Common search terminology includes:
- CJC-1295 No DAC
- CJC-1295 Without DAC
- Mod GRF 1-29
- Mod GRF (1-29)
- Modified GRF (1-29)
These terms are often grouped together commercially, but researchers should use the documentation for the exact product to establish its identity rather than assuming terminology alone proves equivalence.
This becomes particularly important when reviewing scientific literature.
The published human CJC-1295 studies commonly associated with the CJC-1295 name investigated the long-acting DAC-containing compound. Researchers should therefore avoid automatically applying those pharmacokinetic findings to a product marketed as CJC-1295 No DAC.
When comparing products, review:
- Exact compound identity
- DAC status
- Product specifications
- Listed quantity
- Product format
- Current price
- Current availability
- Batch-level documentation where provided
- Analytical information where available
Peptides Lab US also lists With DAC products and CJC-1295/Ipamorelin blends. Those represent separate research configurations and should be evaluated independently.
For laboratory and research purposes only. Not for human consumption.